Clinical impact and cost-effectiveness of updated 2023/24 COVID-19 mRNA vaccination in high-risk populations in the United States

Keya Joshi, Mariia Dronova, Ewelina Paterak, Van Hung Nguyen, Hagit Kopel, James Mansi, Nicolas Van de Velde, Ekkehard Beck
doi: https://doi.org/10.1101/2024.11.15.24317369

Data Availability

The data presented in this study are available upon reasonable request from the corresponding author.

Back to top
Posted November 15, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Clinical impact and cost-effectiveness of updated 2023/24 COVID-19 mRNA vaccination in high-risk populations in the United States
Keya Joshi, Mariia Dronova, Ewelina Paterak, Van Hung Nguyen, Hagit Kopel, James Mansi, Nicolas Van de Velde, Ekkehard Beck
medRxiv 2024.11.15.24317369; doi: https://doi.org/10.1101/2024.11.15.24317369
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area